Tag: Regulation

Fraudulent Practices in California Hospice Sector Threaten Patient Care

Explore the impact of hospice fraud on Medicare and patient care in California. Learn about regulatory challenges and the need for vigilant oversight.

Trump's Initiative to Regulate Insurers and Lower Drug Prices

President Trump's initiative to regulate insurers and PBMs aims to reduce drug prices and ensure savings benefit patients. Discover the impact on healthcare costs.

Enhancing Reliability in Life Insurance Software Platforms

Explore how Chandra Shekhar Pareek enhances reliability in life insurance software through innovative testing, ensuring compliance and operational excellence.

Ohio's Lieutenant Governor Race: Healthcare Accessibility at Stake

David Pepper addresses critical healthcare issues in Ohio's election race, focusing on Medicare and Medicaid access while challenging opponents' views on healthcare costs.

Proposed Changes to Medicare Advantage Plans Spark Debate

Discover the implications of proposed Medicare Advantage changes discussed in Congress, addressing payment increases and patient care concerns.

Alberta Bill 29: Expanded Access to Diagnostic Tests

Discover how Alberta's Bill 29 enhances access to vital diagnostic tests, promoting early diagnosis while balancing public and private healthcare options.

Addressing Medicare Fraud: A Call for Strengthened Oversight and Solutions

Explore urgent measures against Medicare fraud costing billions annually. Learn about crucial oversight to protect beneficiaries and improve healthcare integrity.

New York Auto Insurance Reforms: Lowering Premiums for Drivers

Governor Hochul's initiative aims to reform New York auto insurance, reducing premiums by addressing fraud and litigation costs. Learn more about these proposed changes.

AI Transparency in Health Insurance: The UnitedHealthcare Case

Explore the ruling on UnitedHealthcare's use of AI in coverage denials, highlighting transparency and implications for Medicare Advantage participants.

Legal Challenge to CMS's BEI Program: Implications for FDA and Medicaid

A legal challenge against CMS's BEI program raises concerns over FDA regulation, impacting cannabinoid products in Medicare and competition for FDA-approved treatments.